Gastro-esophageal Reflux Disease (GERD)

DBCOND0077290Digestive System DiseasesOtorhinolaryngologic Diseases

Gastro-esophageal Reflux Disease (GERD) is the indication for 23 drugs in DrugBank. It is covered by 42 curated, structured indications.

Also known as
Gastrooesophageal reflux disease · GERD · Gastroesophageal Reflux Disease · Gastroesophageal Reflux Disease (GERD) · Esophageal Reflux
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT000998299ICD-10K21SNOMED CT102620007MedDRA10015389UMLSC0017168

What you can answer from here — as of October 21, 2026

23Indicated drugsWith each drug's targets and mechanism
Listed above
42Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
319Clinical trialsPhase, status and sponsor resolved per trial
Sign in
96Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Gastro-esophageal Reflux Disease (GERD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In